The association between hypertension and frailty syndrome in older adults remains unclear. There is scarce information about the prevalence of hypertension among frail elderly patients or on its relationship with frailty. Up to one quarter of frail elderly patients present without comorbidity or disability, yet frailty is a leading cause of death. The knowledge and better control of frailty risk factors could influence prognosis. The present study evaluated: (1) the prevalence of hypertension in robust, prefrail, and frail elderly; and (2) factors that might be associated with frailty including hypertension. A cross-sectional study was conducted in 619 older adults at a universitybased outpatient center. Study protocol included sociodemographic data, measures of blood pressure and body mass index, frailty screening according to the internationally validated FRAIL (fatigue, resistance, ambulation, illnesses, and loss of weight) scale, number of comorbidities, drug use assessment, physical activity, cognitive status, and activities of daily living. Ordinal logistic regression was used to evaluate factors associated with frailty. Prevalence of hypertension and frailty was 67.3% and 14.8%, respectively, in the total sample. Hypertension was more prevalent in the prefrail (72.5%) and frail (83%) groups than among controls (51.7%). Hypertension, physical activity, number of prescribed drugs, and cognitive performance were significantly associated with frailty status. Hypertension presented an odds ratio of 1.77 towards frailty (95% confidence interval, 1.21-2.60; P = .002). Hypertension was more prevalent in frail elderly patients and was significantly associated with frailty. Intensive control of hypertension could influence the trajectory of frailty, and this hypothesis should be explored in future prospective clinical trials.
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| INTRODUCTION
Arterial hypertension is highly prevalent among older adults, consisting of reversible cardiovascular risk factors associated with high comorbidity and mortality. 1 The National Health and Nutrition Examination Survey (NHANES) showed that 67% of adults older than 60 years have hypertension in the United States. 2 It is estimated that the percentage of patients with hypertension rises with aging, especially isolated systolic hypertension. 3 Hypertension is also frequently associated with diabetes mellitus, dyslipidemia, and obesity, increasing cardiovascular risk and negative outcomes such as stroke, myocardial infarction, and renal failure. 4 Treatment of hypertension reduces the risk of stroke, cardiovascular events, and total mortality even among the oldest old, according to the HYVET (Hypertension in the Very Elderly Trial). 5 Moreover, a target systolic blood pressure (BP) < 120 mm Hg resulted in lower rates of major cardiovascular events and death from any cause in the SPRINT (Systolic Blood Pressure Intervention Trial). Frailty syndrome is another great health concern for older adults.
It has been defined by an international panel as a multiple etiology syndrome characterized by diminished strength and endurance and reduced physiologic function, leading to increased vulnerability for functional loss. 9 Frailty syndrome was the independent leading cause of death in elderly persons in a 10-year prospective cohort study.
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Similar to hypertension, outcomes associated with frailty include functional and cognitive impairment, hospitalization, and death. 11 The prevalence of frailty in the elderly ranges from 7% to 16%, appears to be greater in women, increases with age, and reaches 28% in the oldest old.
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Only a few studies have explored the potential association between frailty syndrome and hypertension, and only two directly addressed the issue. [13] [14] [15] [16] [17] It appears that frailty is associated with hypertension, but the evidence is still scarce and based on studies with different criteria for the definition of frailty. [13] [14] [15] [16] [17] 
| METHODS

| Participants and Procedures
Data . 18 The cutoff for cognitive impairment was set at < 25 points, and one point was given if the patient had < 11 years of education. 19 The evaluation of activities of daily living was performed with the Functional Activities Questionnaire (FAQ). 20 Frailty was evaluated using the FRAIL-BR scale. 
| The FRAIL scale
The FRAIL (fatigue, resistance, ambulation, illnesses, and loss of weight) scale presents five simple questions to evaluate the presence of frailty components. 22, 23 The scale is based on self-report without any objective measurement. Each question requires a "yes" or "no" answer, with one point for an affirmative response. Scores ranged from zero to five points, classifying patients as robust (0 points), prefrail (1 or 2 points), or frail (≥3 points). The scale assesses the presence of fatigue, muscle resistance, aerobic capacity, disease burden, and weight loss. Fatigue was evaluated by asking participants whether they felt tired most of the time; muscle resistance by participants' report of his/ her capacity to climb a flight of stairs; aerobic reserve by participants'
report of his/her capacity to walk a block independently; disease burden by the presence of five or more of a total of 11 listed diseases; and loss of weight by a decline of ≥5% within the past 6 months.
| Ethics
The study was in accordance with the ethical standards of the 
| RESULTS
| Baseline characteristics of the study population
The clinical and sociodemographic characteristics of the sample are described in Table 1 . Frail patients were older and predominantly women.
There was a higher presence of black race among prefrail and frail compared with robust older adults. Prefrail and frail groups had fewer years of formal education and lower income. Frail elderly showed lower 
| Prevalence of hypertension and association with frailty status
Prevalence of hypertension was 67.3% in the total sample and was higher among the frail (n = 78) (P < .001; Table 2 ) and prefrail (n = 235) (P < .001) groups. All three groups had different prevalence rates without hypertension were similar in clinical and sociodemographic characteristics except for age (70.5 ± 7.0 vs 68.9 ± 6.9, respectively; P = .004), history of stroke (32 vs 4, respectively; P = .007), and previous myocardial infarction (54 vs 11, respectively; P = .005). A significant difference was observed among robust, prefrail, and frail elderly in the use of antihypertensive drugs, except for the use of angiotensin-converting enzyme inhibitors (ACEIs) and calcium channel blockers (CCBs) ( Table 2) . Frail older adults used more diuretics (n = 49) followed by β-blockers (n = 41). Robust, prefrail, and frail elderly patients had significantly different prevalence rates of β-blocker, angiotensin receptor blocker, and diuretic use ( Table 2 ).
The ordinal logistic regression model identified that physical activity, drug use, MoCA score, and hypertension were associated with a higher-order frailty status ( Table 3 ). Practice of physical activity, one additional drug prescribed to the patient, one point lower score on the MoCA (cognitive performance), and having hypertension favored the progression from robust or prefrailty to the next step toward frailty.
The odds ratio (OR) of hypertension was 1.77 (P = .002). Because of a higher prevalence of myocardial infarction and stroke in the hypertensive group, the same ordinal logistic regression was run with these two independent variables. Hypertension continued to be associated 
| DISCUSSION
This is the first cross-sectional study with a large aleatory outpatient population of older adults to evaluate the association between hypertension and frailty syndrome. Hypertension was shown to be a risk factor for frailty syndrome according to the ordinal regression model used in this study. We highlight that the prevalence of frailty was 14.8% in this sample, consistent with the geriatric literature.
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Prevalence of hypertension was also consistent with the literature, 2 and most older adults with frailty presented with hypertension (n = 78, 83% of the frail group; Table 2 ). The use of antihypertensive drugs was different among robust, prefrail, and frail elderly patients, except
for the use of ACEIs and CCBs. Also, being sedentary, taking more prescribed drugs, showing lower cognitive performance, and having hypertension were significantly associated with a higher frailty status (Table 3) .
Five previous studies have investigated the association between hypertension and frailty in observational and cross-sectional designs involving mostly community-dwelling older adults. approximately 37% to 62% in previous studies, and its prevalence among participants with frailty was not reported in any of the trials. These studies also varied widely in their aims, methods, and frailty diagnostic criteria. In one previous study, the risk for frailty was associated with the presence of hypertension. 17 In multiple regression analyses, hypertension was associated with a 1.59 risk for frailty, in agreement with the present findings. However, in our study, we used an easy and common way to identify frailty, which is recommended by international societies. (Table 2 ).
In the present study, we did not find that ACEIs were more prevalent among prefrail or frail groups compared with the use of other antihypertensive drugs. Previously, ACEIs were evaluated in relation to sarcopenia parameters and physical activity. [24] [25] [26] [27] ACEIs were associated with larger lower extremity muscle mass, 26 and longitudinally they appear to slow muscle strength decline in older women with hypertension. 27 In a double-blind randomized trial of 20 weeks, perindopril improved exercise capacity in functionally impaired older adults without heart failure in a 6-minute walking distance. 
| Study limitations
Our study presents some limitations. The sample consisted of elderly patients from an outpatient clinic in a single center. Thus, our findings should be carefully extrapolated to community-dwelling or institutionalized samples. 11 In-depth diagnosis of depression or dementia was not performed, and these diagnoses could be present in the sample and associated with both hypertension and frailty, possibly increasing the prevalence of the latter. Finally, our study was observational and cross-sectional, and thus not designed to establish a causality relationship between hypertension and frailty.
| CONCLUSIONS
Hypertension was an associated risk factor for frailty and was more prevalent among frail older adults. Future longitudinal studies should investigate possible causality associations and the negative outcomes of the concomitant presence of hypertension and frailty.
